AUTHORS

Real Money authors - Stephen Guilfoyle

Stephen Guilfoyle

Stephen "Sarge" Guilfoyle is the founder and President of Sarge986 LLC, a family run trading operation. An NYSE floor trader for over 30 years, Guilfoyle has served as the Chief Market Economist for Stuart Frankel & Co., the U.S. Economist for Meridian Equity Partners, and as a Vice President in Block Trading and Investment Banking with Credit Suisse over the years. Guilfoyle earned his nickname serving as an actual sergeant in reserve components of the US Marine Corps, and US Army while simultaneously working on Wall Street.
Email Stephen Guilfoyle

Recent Articles By The Author

I Think It's Okay to Be Long Home Depot Here

You think people aren't going to fix up their yards, their basements, the roofs? Oh, they will.

50-Day Line in the Sand, Don't Blame Powell, Crude Awakening: Market Recon

Plus, the chart of Novocure Limited is a real attention-grabber while the chart of Apple bears watching.

Is it Too Late to Get Involved With General Electric?

I still think the risk/reward scenario favors bets on the long side.

The Fed's Message, Market Reaction, Snowflake's Blizzard, JFrog, TikTok/Oracle

At least part of the market's negative reaction to the Fed on Wednesday may be tied to two factors.

Here's Why FedEx Has Excelled

Looking at the shares or the options markets, there are several ways to play FDX.

Snowflake's IPO, Fed Day, Trading Adobe, Cut Kraft?: Market Recon

The FOMC, and Powell himself, will have to address the central bank's plan to target average consumer level inflation over time.

TikTok or Not, Here's Why I'm in Microsoft

From CEO Satya Nadella to its deal with BP, the reasons are many, and here's how to trade the stock.

Is It Safe Now? Wall Street Bets on Science, Joy in Metville, Citi's Selloff

Electoral risk remains the monster under the bed, and it only grows as our legislators intentionally choose the blame game over honest cooperation.

How About That Merck and Seattle Genetics Deal?

I am long Merck, not Seattle Genetics, though the one to own now is obviously SGEN.

Challenging Markets, Nvidia Acquires Arm, Oracle Wins TikTok, Vaccine Update

Also, several scheduled events this week, election risk, earnings to watch.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight